Bank of the West’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-15,358
Closed -$320K 308
2016
Q3
$320K Buy
15,358
+1,050
+7% +$26K 0.04% 243
2016
Q2
$385K Buy
+14,308
New +$392K 0.05% 227
2016
Q1
Sell
-17,750
Closed -$516K 285
2015
Q4
$516K Buy
17,750
+3,196
+22% +$88.5K 0.07% 195
2015
Q3
$395K Buy
14,554
+1,128
+8% +$31.9K 0.06% 210
2015
Q2
$368K Buy
13,426
+266
+2% +$7.48K 0.05% 222
2015
Q1
$351K Buy
+13,160
New +$303K 0.05% 226

Other funds holding NVO

Bank of the West's NVO Position: Q4 2016 in Review

Bank of the West sold out of Novo Nordisk (NVO) in Q4 2016, closing a stake of 15,358 shares — an estimated $320K sold.

Bank of the West first reported a position in NVO in Q1 2015 and held it in 6 quarters. The position peaked at $516K in Q4 2015. 483 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

  • Bank of the West reported no remaining Novo Nordisk position as of Q4 2016 after selling out during the quarter.
  • Bank of the West sold 15,358 Novo Nordisk shares in Q4 2016, an estimated $320K.
  • Bank of the West first reported a position in Novo Nordisk in Q1 2015 and held it in 6 quarters.
  • Bank of the West's Novo Nordisk position peaked at $516K in Q4 2015.
  • 483 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on Bank of the West's 13F filing for Q4 2016, filed 12 Jan 2017.